Results 151 to 160 of about 3,403,053 (289)

Medical Ethics Books [PDF]

, 1951
Kelly, Gerald
core   +1 more source

Research ethics education needs assessment in Serbian medical researchers [PDF]

Vida Jeremić Stojković, Smiljana Cvjetković, Željka Stamenković, Janko Janković, Pavle Piperac, Dragana Ignjatovic Ristic, Ivanka Marković, Rosamond Rhodes   +7 more
openalex   +1 more source

Journal of Medical Ethics- http://www.jmedethics.com [PDF]

, 2000
Aziz Sheikh, M Power, R Horton, N Goodman, D Shapiro, N Wenger, M Shapiro, J Smith, R Bhopal, J Rankin, E Mccoll, L Thomas, E Kaner, R Stacey, C Currie, J Jia, R Smith, R Horton, K Chakravarty, T Scott, T Albert, Williams, R Smith, Anonymous   +23 more
openalex   +1 more source

Crucial parameters for precise copy number variation detection in formalin‐fixed paraffin‐embedded solid cancer samples

Molecular Oncology, EarlyView.
This study shows that copy number variations (CNVs) can be reliably detected in formalin‐fixed paraffin‐embedded (FFPE) solid cancer samples using ultra‐low‐pass whole‐genome sequencing, provided that key (pre)‐analytical parameters are optimized.
Hanne Goris, Vasiliki Siozopoulou, Léon C van Kempen, Anne Sieben, Ella Roelant, Stig Hellemans, Elyne Backx, Laure Sorber, Koen De Winne, Senada Koljenović, Karen Zwaenepoel   +10 more
wiley   +1 more source

Dammarenediol II enhances etoposide‐induced apoptosis by targeting O‐GlcNAc transferase and Akt/GSK3β/mTOR signaling in liver cancer

Molecular Oncology, EarlyView.
Etoposide induces DNA damage, activating p53‐dependent apoptosis via caspase‐3/7, which cleaves PARP1. Dammarenediol II enhances this apoptotic pathway by suppressing O‐GlcNAc transferase activity, further decreasing O‐GlcNAcylation. The reduction in O‐GlcNAc levels boosts p53‐driven apoptosis and influences the Akt/GSK3β/mTOR signaling pathway ...
Jaehoon Lee, Byung‐Cheol Han, Gi‐Bang Koo, Jihye Park, Mijin Kwon, Young Bin Park, Jae‐Mun Choi, Seung‐Ho Lee, Sangho Roh   +8 more
wiley   +1 more source

Ethics in Medical Training [PDF]

, 1981
Elborn, Joseph S.
core   +1 more source

Roadmap to Success: Fostering Medical Professionalism and Ethics in Pakistan

openalex   +1 more source

The Pond Report—A Report of a Working Party on the Teaching of Medical Ethics

, 1987
J.G.G. Ledingham
openalex   +1 more source

The Annual Intensive Course on Medical Ethics [PDF]

, 2000
D Manning, Wirral Hospital, Wirral, S Conroy, J Mcintyre, I Choonara, M Samuels, J Raine, T Wright, J Alexander, K Lockyer, S Spencer, D Rothman, N Perlman, J Freedman, R Abramovitch, H Whyte, H Kirpalani, M Perlman, P Allmark, C Snowdon, J Garcia, D Elbourne, S Mason, S Harth, Y Thong, M Van Stuijvenberg, M Suur, S De Vos, Gch Tjiang, E Steyerberg, G Derksen-Lubsen, S Hewlett, S Harth, Y Thong, W Silverman, J Walterspiel, J Adams, J Wegener, C Morley, N Modi, J Zupancic, Gillie Streiner, D Watts, J Schmidt, B, L Mutch, R King, C Rogers, J Tyson, K Kennedy, S Broyles, J Hickman, I Kennedy, R Sells, A Daar, R Guttmann, R Hovenberg, M Lock, J Lantos, B Schmidt, Gillie Caco, C Roberts, J Roberts, R, M Kremers, D Whisnant, L Lowder, L Gregg, A Edwards, D Azzopardi   +70 more
openalex   +1 more source

The PI3Kδ inhibitor roginolisib (IOA‐244) preserves T‐cell function and activity

Molecular Oncology, EarlyView.
Identification of novel PI3K inhibitors with limited immune‐related adverse effects is highly sought after. We found that roginolisib and idelalisib inhibit chronic lymphocytic leukemia (CLL) cells and Treg suppressive functions to similar extents, but roginolisib affects cytotoxic T‐cell function and promotion of pro‐inflammatory T helper subsets to a
Elise Solli, Alessio Bevilacqua, Mathias Wenes, Denis Migliorini, Lars van der Veen, Sigrid S Skånland, Giusy Di Conza, Kjetil Taskén   +7 more
wiley   +1 more source